Best Options Play: Leverage FDA approval in this $2.55 stock into potential 300% options gains
Today's Financial News - Posted March 19, 2009
A tiny medical microcap stock expects FDA approval on Monday. Using options to leverage to expected upward momentum could result in 300% gains!
by J. Christoph Amberger
Baltimore—TFN: “The major indexes may be well into negative territory,” writes TFN’s options oracle Andrew Snyder in his internal brief: “But the action won’t bring a frown to the face of options’ investors. In fact, for us, there was one key index well into positive territory—the Volatility Index (VIX). As this key measure of options spreads rose by more than 8% today, options investors were able to stand back and know the value of their positions were on the rise.”
At TFN Strategic Trader, we’ re well positioned to take advantage of this volatile market. Just after tomorrow’s opening bell, I will be unleashing my latest pick, my second of the week.
If my predictions are true, investors that follow my advice could be sitting on triple-digit gains as early as Monday. This stock is ready to pop. It all comes down to just one vote. And the options I have picked could leverage a doubling of the underlying share price into a tripling or even quadrupling of our options play. TFN Strategic Traders should expect my special alert between the opening bell and 10 o’clock tomorrow morning.
Here’s your link to the details of joining TFN Strategic Trader.
Next Article: AIG Bonuses: “The Putinization of the American economy”
Be the first to leave a reply.
Your comments are welcome

